Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

被引：0
|
作者：
Laura Obici
Senda Ajroud-Driss
Kon-Ping Lin
John L. Berk
Julian D. Gillmore
Parag Kale
Haruki Koike
David Danese
Emre Aldinc
Chongshu Chen
John Vest
David Adams
机构：
[1] IRCCS Fondazione Policlinico San Matteo,Amyloidosis Research and Treatment Centre
[2] Northwestern University Feinberg School of Medicine,Department of Neurology
[3] Taipei Veterans General Hospital,Department of Neurology
[4] Boston Medical Center,National Amyloidosis Centre, Royal Free Hospital
[5] University College London,Department of Neurology
[6] Baylor University Medical Center,Neurology Department
[7] Nagoya University Graduate School of Medicine,undefined
[8] Alnylam Pharmaceuticals,undefined
[9] Université Paris-Saclay,undefined
[10] U1195,undefined
[11] INSERM,undefined
[12] AP-HP,undefined
[13] CHU Bicêtre,undefined
来源：
Neurology and Therapy | 2023年 / 12卷 / 5期
关键词：
ATTRv amyloidosis; hATTR amyloidosis; Nutritional status; Physical function; Polyneuropathy; Quality of life; RNA interference; Vutrisiran;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1759 / 1775
页数：16
相关论文
共 50 条
  • [41] Hereditary transthyretin-mediated amyloidosis with polyneuropathy: baseline anthropometric, demographic and disease characteristics of patients from a reference center
    Cunha Sequeira, Vanessa Cristina
    Penetra, Maria Alice
    Duarte, Lisa
    de Azevedo, Fernanda Reis
    Santa Rosa Sayegh, Raphael
    Pedrosa, Roberto Coury
    Cruz, Marcia Waddington
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (03) : 262 - 269
  • [42] The V122I Mutation in Hereditary Transthyretin-Mediated Amyloidosis is Significantly Associated with Polyneuropathy
    Nioi, Paul
    Parker, Meg M.
    Damrauer, Scott M.
    Rader, Daniel J.
    Ticau, Simina
    Erbe, David
    Hinkle, Greg
    NEUROLOGY, 2020, 94 (15)
  • [43] The V122I Mutation in Hereditary Transthyretin-Mediated Amyloidosis is Significantly Associated with Polyneuropathy
    Parker, Margaret M.
    Damrauer, Scott M.
    Rader, Daniel J.
    Ticau, Simina
    Erbe, David
    Hinkle, Gregory
    Nioi, Paul
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S110 - S110
  • [44] The V122I Variant in Hereditary Transthyretin-Mediated Amyloidosis is Significantly Associated with Polyneuropathy
    Parker, Margaret M.
    Damrauer, Scott M.
    Tcheandjieu, Catherine
    Erbe, David
    Aldinc, Emre
    Hawkins, Philip N.
    Gillmore, Julian
    Hull, Leland E.
    Lynch, Julie A.
    Joseph, Jacob
    Ticau, Simina
    Flynn-Carroll, Alexander O.
    Deaton, Aimee M.
    Ward, Lucas D.
    Assimes, Themistocles L.
    Tsao, Philip S.
    Chang, Kyong-Mi
    Rader, Daniel J.
    Fitzgerald, Kevin
    Vaishnaw, Akshay K.
    Hinkle, Gregory
    Nioi, Paul
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S96 - S96
  • [45] Impact of Patisiran, an investigational RNAi Therapeutic, on nutritional status in patients with hereditary Transthyretin-Mediated Amyloidosis
    Obici, L.
    Coelho, T.
    Adams, D.
    Gonzalez-Duarte, A.
    O'Riordan, W.
    Yang, C-C.
    Yamashita, T.
    Kristen, A.
    Tournev, I.
    Schmidt, H.
    Berk, J.
    Lin, K-P.
    Gandhi, P.
    Sweetser, M.
    Chen, J.
    Goyal, S.
    Gollob, J.
    Suhr, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 17 - 17
  • [46] Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
    Obici, Laura
    Berk, John L.
    Gonzalez-Duarte, Alejandra
    Coelho, Teresa
    Gillmore, Julian
    Schmidt, Hartmut H. -J.
    Schilling, Matthias
    Yamashita, Taro
    Labeyrie, Celine
    Brannagan, Thomas H., III
    Ajroud-Driss, Senda
    Gorevic, Peter
    Kristen, Arnt V.
    Franklin, Jaclyn
    Chen, Jihong
    Sweetser, Marianne T.
    Wang, Jing Jing
    Adams, David
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2020, 27 (03): : 153 - 162
  • [47] NEUROPATHY IMPAIRMENT AND NUTRITIONAL STATUS WITH EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS
    Conceicao, Isabel
    Wixner, Jonas
    Berk, John
    Adams, David
    Polydefkis, Michael
    Attarian, Shahram
    Gillmore, Julian
    Dyck, P. James
    Coelho, Teresa
    Chen, Jersey
    Hardy, Elise
    Kwoh, Jesse
    Natman, Jonatan
    Cruz, Marcia Waddington
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S138 - S138
  • [48] Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
    Conceicao, Isabel
    Berk, John L.
    Weiler, Markus
    Kowacs, Pedro A.
    Dasgupta, Noel R.
    Khella, Sami
    Chao, Chi-Chao
    Attarian, Shahram
    Kwoh, T. Jesse
    Jung, Shiangtung W.
    Chen, Jersey
    Viney, Nicholas J.
    Yu, Rosie Z.
    Gertz, Morie
    Masri, Ahmad
    Cruz, Marcia Waddington
    Coelho, Teresa
    JOURNAL OF NEUROLOGY, 2024, 271 (10) : 6655 - 6666
  • [49] COST OF INOTERSEN AND PATISIRAN FOR THE TREATMENT OF ADULTS WITH POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IN CANADA, GERMANY, AND ITALY
    Brown, D.
    Vera-Llonch, M.
    Shaff, M.
    Rolli, A.
    Vega, M.
    Blum, M.
    Nestler-Parr, S.
    Jiresch, M.
    Weycker, D.
    VALUE IN HEALTH, 2020, 23 : S606 - S607
  • [50] Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
    Ticau, Simina
    Sridharan, Gautham, V
    Tsour, Shira
    Cantley, William L.
    Chan, Amy
    Gilbert, Jason A.
    Erbe, David
    Aldinc, Emre
    Reilly, Mary M.
    Adams, David
    Polydefkis, Michael
    Fitzgerald, Kevin
    Vaishnaw, Akshay
    Nioi, Paul
    NEUROLOGY, 2021, 96 (03) : E412 - E422
12345